Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bamidele O Tayo, PhD
Loyola University Chicago
Principal Investigator - Lewis Hsu, MD
University of Illinois at Chicago
Principal Investigator - Richard S Cooper, MD
Loyola University Chicago
Principal Investigator - Titilola S Akingbola, MBBS, FWACP
University of Ibadan College of Medicine, Nigeria
Principal Investigator - Victor R Gordeuk, MD
University of Illinois at Chicago
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Ibadan College of Medicine
Ibadan, Oyo State, Nigeria
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 30 Sept 2017
- Completion
- 31 Dec 2022
- Last update posted
- 9 Mar 2023
- Registered enrollment
- 53
- Registry id
- NCT02149537
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.